- Home
- MRSN vs SDST Comparison
MRSN vs SDST Comparison
Compare MRSN & SDST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRSN
- SDST
- Stock Information
- Founded
- MRSN 2001
- SDST 2022
- Country
- MRSN United States
- SDST United States
- Employees
- MRSN N/A
- SDST N/A
- Industry
- MRSN Biotechnology: Pharmaceutical Preparations
- SDST Blank Checks
- Sector
- MRSN Health Care
- SDST Finance
- Exchange
- MRSN Nasdaq
- SDST Nasdaq
- Market Cap
- MRSN 40.7M
- SDST 33.1M
- IPO Year
- MRSN 2017
- SDST N/A
- Fundamental
- Price
- MRSN $0.32
- SDST $0.50
- Analyst Decision
- MRSN Buy
- SDST Strong Buy
- Analyst Count
- MRSN 3
- SDST 2
- Target Price
- MRSN $4.00
- SDST $1.73
- AVG Volume (30 Days)
- MRSN 2.3M
- SDST 523.1K
- Earning Date
- MRSN 05-15-2025
- SDST 05-14-2025
- Dividend Yield
- MRSN N/A
- SDST N/A
- EPS Growth
- MRSN N/A
- SDST N/A
- EPS
- MRSN N/A
- SDST N/A
- Revenue
- MRSN $40,497,000.00
- SDST N/A
- Revenue This Year
- MRSN N/A
- SDST $4,114.37
- Revenue Next Year
- MRSN N/A
- SDST N/A
- P/E Ratio
- MRSN N/A
- SDST N/A
- Revenue Growth
- MRSN 9.88
- SDST N/A
- 52 Week Low
- MRSN $0.26
- SDST $0.41
- 52 Week High
- MRSN $3.50
- SDST $28.38
- Technical
- Relative Strength Index (RSI)
- MRSN 41.87
- SDST N/A
- Support Level
- MRSN $0.35
- SDST N/A
- Resistance Level
- MRSN $0.44
- SDST N/A
- Average True Range (ATR)
- MRSN 0.04
- SDST 0.00
- MACD
- MRSN -0.00
- SDST 0.00
- Stochastic Oscillator
- MRSN 8.48
- SDST 0.00
About MRSN Mersana Therapeutics Inc.
Mersana Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing antibody-drug conjugates (ADCs) that offer a clinically meaningful benefit for cancer patients with unmet needs. The Company's next-generation ADC platforms include Dolasynthen, which delivers a proprietary auristatin payload, and Immunosynthen, which delivers a proprietary stimulator of interferon genes (STING) agonist payload. Its pipeline includes Emi-Le (XMT-1660), XMT-2056, XMT-2068, and XMT-2175.
About SDST Stardust Power Inc. Common Stock
Stardust Power Inc is developing a lithium refinery at its Facility in Muskogee, Oklahoma, with planned capacity of producing up to 50,000 metric tons per annum of BGLC once fully operational. The company will source lithium brine feedstock from various suppliers and may make investments upstream to secure additional feedstock. The Company seeks to sell its products to electric vehicle (EV) manufacturers as the primary market, with potential applications in other areas such as battery manufacturers, the U.S. military, and original equipment manufacturers (OEMs).